357 related articles for article (PubMed ID: 29191914)
21. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype.
Titos E; Rius B; González-Périz A; López-Vicario C; Morán-Salvador E; Martínez-Clemente M; Arroyo V; Clària J
J Immunol; 2011 Nov; 187(10):5408-18. PubMed ID: 22013115
[TBL] [Abstract][Full Text] [Related]
22. Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse.
Harrison JL; Rowe RK; Ellis TW; Yee NS; O'Hara BF; Adelson PD; Lifshitz J
Brain Behav Immun; 2015 Jul; 47():131-40. PubMed ID: 25585137
[TBL] [Abstract][Full Text] [Related]
23. Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation.
Zhang MJ; Sansbury BE; Hellmann J; Baker JF; Guo L; Parmer CM; Prenner JC; Conklin DJ; Bhatnagar A; Creager MA; Spite M
Circulation; 2016 Aug; 134(9):666-680. PubMed ID: 27507404
[TBL] [Abstract][Full Text] [Related]
24. RG7212 anti-TWEAK mAb inhibits tumor growth through inhibition of tumor cell proliferation and survival signaling and by enhancing the host antitumor immune response.
Yin X; Luistro L; Zhong H; Smith M; Nevins T; Schostack K; Hilton H; Lin TA; Truitt T; Biondi D; Wang X; Packman K; Rosinski J; Berkofsky-Fessler W; Tang JP; Pant S; Geho D; Vega-Harring S; Demario M; Levitsky H; Simcox M
Clin Cancer Res; 2013 Oct; 19(20):5686-98. PubMed ID: 23974006
[TBL] [Abstract][Full Text] [Related]
25. Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice.
Klein CP; Sperotto ND; Maciel IS; Leite CE; Souza AH; Campos MM
Neuropharmacology; 2014 Nov; 86():57-66. PubMed ID: 24929111
[TBL] [Abstract][Full Text] [Related]
26. Rapid and sustained antidepressant effects of resolvin D1 and D2 in a chronic unpredictable stress model.
Ishikawa Y; Deyama S; Shimoda K; Yoshikawa K; Ide S; Satoh M; Minami M
Behav Brain Res; 2017 Aug; 332():233-236. PubMed ID: 28610917
[TBL] [Abstract][Full Text] [Related]
27. Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.
Kain V; Ingle KA; Colas RA; Dalli J; Prabhu SD; Serhan CN; Joshi M; Halade GV
J Mol Cell Cardiol; 2015 Jul; 84():24-35. PubMed ID: 25870158
[TBL] [Abstract][Full Text] [Related]
28. Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression.
Kaneda MM; Cappello P; Nguyen AV; Ralainirina N; Hardamon CR; Foubert P; Schmid MC; Sun P; Mose E; Bouvet M; Lowy AM; Valasek MA; Sasik R; Novelli F; Hirsch E; Varner JA
Cancer Discov; 2016 Aug; 6(8):870-85. PubMed ID: 27179037
[TBL] [Abstract][Full Text] [Related]
29. Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation.
Qu X; Zhang X; Yao J; Song J; Nikolic-Paterson DJ; Li J
J Pathol; 2012 Dec; 228(4):506-19. PubMed ID: 22610993
[TBL] [Abstract][Full Text] [Related]
30. Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers.
Gray MJ; Gong J; Hatch MM; Nguyen V; Hughes CC; Hutchins JT; Freimark BD
Breast Cancer Res; 2016 May; 18(1):50. PubMed ID: 27169467
[TBL] [Abstract][Full Text] [Related]
31. Tumor-fibroblast interactions stimulate tumor vascularization by enhancing cytokine-driven production of MMP9 by tumor cells.
Limoge M; Safina A; Beattie A; Kapus L; Truskinovsky AM; Bakin AV
Oncotarget; 2017 May; 8(22):35592-35608. PubMed ID: 28423685
[TBL] [Abstract][Full Text] [Related]
32. Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapy.
Liu M; Wang H; Liu L; Wang B; Sun G
J Transl Med; 2016 Jun; 14(1):155. PubMed ID: 27246873
[TBL] [Abstract][Full Text] [Related]
33. RvD1 inhibits TNFα-induced c-Myc expression in normal intestinal epithelial cells and destabilizes hyper-expressed c-Myc in colon cancer cells.
Zhong X; Lee HN; Surh YJ
Biochem Biophys Res Commun; 2018 Feb; 496(2):316-323. PubMed ID: 29305860
[TBL] [Abstract][Full Text] [Related]
34. Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses.
Chiurchiù V; Leuti A; Dalli J; Jacobsson A; Battistini L; Maccarrone M; Serhan CN
Sci Transl Med; 2016 Aug; 8(353):353ra111. PubMed ID: 27559094
[TBL] [Abstract][Full Text] [Related]
35. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice.
Akagi D; Chen M; Toy R; Chatterjee A; Conte MS
FASEB J; 2015 Jun; 29(6):2504-13. PubMed ID: 25777995
[TBL] [Abstract][Full Text] [Related]
36. Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages.
Recchiuti A; Codagnone M; Pierdomenico AM; Rossi C; Mari VC; Cianci E; Simiele F; Gatta V; Romano M
FASEB J; 2014 Jul; 28(7):3090-102. PubMed ID: 24692596
[TBL] [Abstract][Full Text] [Related]
37. Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro.
Rey C; Nadjar A; Buaud B; Vaysse C; Aubert A; Pallet V; Layé S; Joffre C
Brain Behav Immun; 2016 Jul; 55():249-259. PubMed ID: 26718448
[TBL] [Abstract][Full Text] [Related]
38. Phototherapy-Induced Antitumor Immunity: Long-Term Tumor Suppression Effects via Photoinactivation of Respiratory Chain Oxidase-Triggered Superoxide Anion Burst.
Lu C; Zhou F; Wu S; Liu L; Xing D
Antioxid Redox Signal; 2016 Feb; 24(5):249-62. PubMed ID: 26413929
[TBL] [Abstract][Full Text] [Related]
39. Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology.
Rajasagi NK; Bhela S; Varanasi SK; Rouse BT
J Leukoc Biol; 2017 Nov; 102(5):1159-1171. PubMed ID: 28584076
[TBL] [Abstract][Full Text] [Related]
40. Palmatine from Mahonia bealei attenuates gut tumorigenesis in ApcMin/+ mice via inhibition of inflammatory cytokines.
Ma WK; Li H; Dong CL; He X; Guo CR; Zhang CF; Yu CH; Wang CZ; Yuan CS
Mol Med Rep; 2016 Jul; 14(1):491-8. PubMed ID: 27175745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
